Loading organizations...
Loading organizations...
Developing novel mesenchymal stem cell therapies.
AffyXell Therapeutics has raised $7.3M across 1 funding round.
AffyXell Therapeutics has raised $7.3M in total across 1 funding round.
AffyXell Therapeutics has raised $7.3M in total across 1 funding round.
AffyXell Therapeutics's investors include Gyeongnam Venture Investment, Kolon Investment, Samsung, Shinhan Securities, Shinhan Venture Investment, Smilegate Investment, Stonebridge Ventures.
AffyXell Therapeutics has raised $7.3M across 1 funding round. Most recently, it raised $7.3M Series A in February 2021.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Feb 1, 2021 | $7.3M Series A | Gyeongnam Venture Investment, Kolon Investment, Samsung, Shinhan Securities, Shinhan Venture Investment, Smilegate Investment, Stonebridge Ventures |